Dykema (Cannabis Law Blog)

APRIL 20, 2023

iii] The Act was originally intended for patients with intractable epilepsy and was expanded in 2019 and 2021 to include other physical and mental illnesses (cancer, multiple sclerosis, post-traumatic stress disorder). [iv] 2 – 3 (2023). Specifically, H.B. Code § 169.001 et seq. [vi] vi] [link] [vii] Tex. 1805, 88th Leg., viii] Id. [ix]

Law 74

Law Chronic Pain Conditions Medicine 74

Veriheal

SEPTEMBER 15, 2023

The bill was enacted as soon as Governor Nathan Deal signed it, permitting possession for eight qualifying medical conditions but not allowing cultivation or distribution within the state. In April 2019, House Bill 324 was approved, enabling in-state cultivation and the sale of low-THC oil.

Programs 62

Programs Legalization Oil Conditions 62

Cannabis Law Report

FEBRUARY 4, 2019

Winter Edition 2019 – Cannabis. 2019 Legislative Session – Agency Proposed Legislation. On January 9, 2019 the Board approved a motion to make the effective date for all marijuana product, packaging and labeling requirements Jan 1, 2020. The 2019 legislative session began January 14 and runs through April 28, 2019.

Topical 65

Topical Packaging Retail Legislation 65

The Cannigma

MARCH 18, 2023

Medical: early stages Recreational: illegal As of March 2023, cannabis is illegal for both recreational purposes in Barbados. While medical cannabis laws were introduced in 2019, the program is still in its early stages. The possession, cultivation, sale, and trafficking of cannabis are all illegal and punishable by law.

Law 52

Law Chronic Pain Cultivation Recreational 52

Illinois News Joint

JANUARY 5, 2023

In addition to three social equity adult use cannabis dispensaries that opened in 2022, 189 other conditional licensees are in the process of receiving full dispensary license from IDFPR. IDFPR also announced in December 2022 that applications for the next round of cannabis dispensary licenses would be accepted starting January 30, 2023.

Dispensary 90

Dispensary Recreational Cannabis Collective 90

Canna Law Blog

NOVEMBER 21, 2021

In 2019, when Denver opened up the psychedelics floodgates by legalizing psilocybin, it was totally unclear what the future of regulated psychedelics will look like. In all likelihood, FDA-approved MDMA would be prescribed and administered in very similar conditions. Ketamine clinics are popping up around the county.

Decriminalization 83

Decriminalization DEA Conditions Food 83

Cannabis Law Report

FEBRUARY 28, 2022

The Board is made up of people who were appointed by the governor to create recommendations for the rules for the state’s legal psilocybin services, which begin in January 2023. A disclosure of my own: I went to Synthesis in 2019 for a 3-day retreat.). Full report. Oregon Psilocybin Advisory Board Overview.

Research and Development 105

Research and Development Safety Policy Conditions 105

Cannabis Law Report

DECEMBER 9, 2019

In fact, the Brightfield Group claims that the CBD market may reach $24 billion by 2023, good news for businesses such as Next Green Wave, Inc. That said, research conducted to date has been promising, with CBD demonstrating the potential for aiding with a wide range of health conditions and resulting symptoms.

Pets 59

Pets CBD Research and Development Epilepsy 59

MMJ Recs

DECEMBER 13, 2023

In 2019, the Texas legislature further expanded the Compassionate Use Program with the passage of House Bill 3703, which added several qualifying medical conditions, including terminal cancer, autism, and multiple sclerosis, among others. This marked the first step toward recognizing the potential medical benefits of marijuana.

Dispensary 52

Dispensary Patients Marijuana Epilepsy 52

PrestoDoctor

FEBRUARY 13, 2023

Louis Skyline – Gateway Arch Getting your Missouri medical marijuanas card in 2023 is still beneficial. Starting in the Fall of 2019, Missouri started issuing medical marijuana ID card. Beginning May 3rd, 2023, dispensaries will be required to scan patient and caregiver cards at the time of purchase.

Marijuana 52

Marijuana Conditions Patients Cultivation 52

The Cannigma

JULY 5, 2022

The program was legalized in 2015 and patients with qualifying conditions can get a prescription for up to 20oz of low THC oil, capsules, patches, or lotion. oz of 5% or less THC oil for medical patients with qualifying conditions. In-state cultivation and distribution weren’t legalized until 2019.

Law 96

Law Decriminalization Programs Patients 96

MJ Business Attorneys

JULY 29, 2019

The letter accused Curaleaf of “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases.” CBD sales by 2023. billion is U.S.

CBD 133

CBD Pets Media Food 133

Cannabis Law Report

AUGUST 4, 2021

We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. Core Business organic growth was 16% in H1 2021 vs. H1 2019, and close to 13% vs. H1 2019 corrected for the EUR 62m estimated missing revenues from the cyber-attack of 2 June 2019. for the three historic TIC leaders.

Business 105

Business Research and Development Environment Food 105

Cannabis Law Report

MAY 12, 2022

Lophora has previously secured grant funding from the BioInovation Institute (Novo Nordisk Foundation) and continues to characterise its lead candidates, aiming to initiate clinical trials in 2023. Lophora expects LPH-5 to be IND ready in Q4 2022 and plans to begin first-in-human trials in 2023.

Medicine 52

Medicine Research and Development Clinical Trials Treatment 52

Veriheal

JANUARY 12, 2023

Approximately 3,000 patients who suffer from debilitating conditions like chronic pain and epilepsy will partake in the project, which is due to end in March 2023. In November 2019, the founder of the world-famous circus Cirque du Soleil got tangled up in drug charges.

Medicine 95

Medicine Chronic Pain Consumption Cannabis 95

Cannabis Law Report

MARCH 10, 2022

All other terms of the credit facility will remain the same as before, including the maturity date of June 30, 2023. As consideration for the Amendment, the Company has issued a total of 500,000 common shares to the Agent and certain affiliates of the Agent based on an issue price of $0.10 per common share. “

Environment 52

Environment Conditions Cultivation Recreational 52

Cannabis Law Report

AUGUST 21, 2019

Aug 21, 2019 . Illinois remains the epicenter of marijuana legalization in 2019. On the medical side, Governor Pritzker signed Senate Bill 2023 , which expands and makes permanent the Compassionate Use of Medical Cannabis Program Act in Illinois. This brings the total qualifying medical conditions to 52.

Programs 45

Programs Recreational Chronic Pain Dispensary 45

The Cannigma

AUGUST 24, 2022

At the end of the 2022 legislative session, lawmakers voted to form a committee dedicated to exploring the creation of a program for the 2023 legislative session. Kansas does not have a medical marijuana program. Lawmakers tried to pass two bills in 2022 to create a legal medical program, but both failed.

Law 72

Law Seed-To-Sale Oil THC 72

Veriheal

SEPTEMBER 2, 2022

Individuals in the country with conditions such as Parkinson’s disease, depression, insomnia, ADHD, multiple sclerosis, anxiety, chronic pain, and epilepsy have embraced the option of medical cannabis. Starting in 2023, the bill would allow for industrial hemp and medical cannabis production on up to 150 hectares of land.

Chronic Pain 57

Chronic Pain Patients Decriminalization Cannabis 57

Cannabis Law Report

SEPTEMBER 16, 2022

Arkansas dispensaries began serving qualified patients in 2019. The law authorizes doctors to prescribe cannabis for a long list of specific qualifying conditions, as well as any condition the doctor “considers debilitating to an individual patient” that the doctor “is qualified through [their] medical education and training to treat.”

Law 52

Law Programs Cultivation Dispensary 52

The Cannigma

JANUARY 12, 2022

In 2019, nearly 60,000 Finnish citizens signed a petition to decriminalize cannabis , surpassing the threshold of 50,000 signatures required for the parliament to consider the matter. They have until the end of the current parliament, in 2023, to do so. The push for legalization of weed in Finland.

Legalization 52

Legalization Decriminalization Hash Hemp 52

Cannabis Law Report

AUGUST 1, 2019

On June 25, 2019, Illinois Governor J.B. Those approved for Early Approval Cultivation Licenses may begin sales on December 1, 2019. Separately, the Illinois General Assembly has passed SB 2023, which aims to stabilize and make permanent the State’s medical cannabis program. Authored by T.O. Odutayo & Kevin Young.

Dispensary 40

Dispensary Cultivation Programs Cannabis 40

Cannabis Law Report

MAY 31, 2022

On March 5, 2019, the U.S. The only opportunity to currently participate would be through an active clinical trial or via an argument under the Right to Try Act of 2018 (an act which provides a pathway for patients with life-threatening diseases or conditions to access unapproved treatments). Non-Commercial Operations. Schedule I.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Veriheal

APRIL 14, 2022

The pilot program, which involves participation from approximately 3,000 patients who suffer from debilitating conditions, extends until March 2023. million French people used cannabis on a regular basis in 2019. The ANSM has been leading a strictly regulated medical cannabis pilot program for the best part of a year.

Cultivation 52

Cultivation Supply Chain Research and Development Programs 52

Cannabis Law Report

NOVEMBER 23, 2019

Several declarations have been published by the local government in this sense about the project, and several special conditions have been already attributed. CAMPUS KANNABEIRA represents an estimated overall investment of more than €20m in the triennium of 2019-2023. Jose Maraver. CEO & Founder. Green Donation Lda. +34

Pharmaceutical 45

Pharmaceutical Research and Development Cultivation Environment 45

Cannabis Law Report

JUNE 28, 2021

Merger includes retail, distribution and cultivation capabilities in the limited license market where adult-use sales are expected to reach up to US$230 million in 2023[1]. Retail sales in Vermont for adult-use cannabis products are expected to begin in the fall of 2022, with sales expected to reach up to US$230 million in 2023.

Retail 59

Retail Dispensary Packaging History 59

Cannabis Law Report

NOVEMBER 8, 2021

1 The transaction is expected to close in the second half of 2022, subject to customary approvals and conditions. An incremental earnout of up to 1 million Curaleaf Shares may be paid in 2023 based on the business exceeding certain EBITDA targets for the year 2022. Transaction Advisors.

Retail 52

Retail Dispensary Vaping Topical 52

Veriheal

MARCH 29, 2023

However, a 2023 study debunks many myths about the potential dangers of legalizing cannabis. How Several Sources of Data Were Used in the Research In 2019, an estimated 48.2 Always consult a physician before making any decision on the treatment of a medical condition. Following more than 63 million participants from Jan.

Legalization 57

Legalization Data Policy Cannabis 57

Cannabis Law Report

NOVEMBER 18, 2021

TGOD’s Common Shares and Warrants issued under the indentures dated December 19, 2019 , June 12, 2020 , October 23, 2020 and December 10, 2020 trade on the CSE under the symbol “TGOD”, “TGOD.WS”, “TGOD.WR”, “TGOD.WA”, and “TGOD.WB” respectively. TGOD’s Common Shares trade in the U.S. on the OTCQX under the symbol “TGODF”.

Research and Development 52

Research and Development Seed-To-Sale Supply Chain Events 52

NORML

MAY 31, 2019

Legislation is pending, Senate Bill 236, to allow qualifying patients with certain debilitating conditions to use and safely access medical cannabis. Update : SB 2023 was approved by the House Judiciary Criminal Committee on 5/29/19. Send a message to your federal lawmakers in support of this important legislation.

Legislation 110

Legislation Access Banking Hemp 110

Cannabis Law Report

SEPTEMBER 24, 2021

billion during 2019-2023. Market condition. Backed with competitive intelligence and benchmarking, our research reports on the cannabis testing market are designed to provide entry support, customer profile & M&As as well as go-to-market strategy support. Download a free sample report now! Five Forces Analysis.

Research and Development 52

Research and Development Access Environment Cannabis 52

Cannabis Law Report

APRIL 12, 2022

However, in 2019, California lawmakers reauthorized the program, this time with a 2-year window. After July 1, 2023, all provisional license renewals will require a demonstration of CEQA compliance. Additionally, some local equity applicants may apply through March 31, 2023. City of San Diego (2019) 7 Cal.5th ENDNOTES.

Compliance 52

Compliance Compliance Programs Cannabis 52

Cannabis Law Report

DECEMBER 21, 2021

While it might feel like Mindset Pharma was a little late to the space, it was among the first companies to file patents for novel molecules back in early 2020 and was founded back in 2019. The company, which began trading on the OTC and Frankfurt Stock exchanges in October, has plans to open as many as 120 more clinics by 2023.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

NORML

MARCH 22, 2019

Senate Bill 34 would exempt compassionate care programs from paying state cannabis taxes when they are providing free medical cannabis to financially disadvantaged people living with serious health conditions. SB 2023 was approved by the Senate Financial Institutions Committee on 3/20. CA resident? IL resident? NH resident? New Mexico.

Legislation 135

Legislation Hemp Patients Compliance 135

Cannabis Law Report

MAY 29, 2022

In May 2019, Denver became the first city to decriminalize psilocybin, followed by Oakland, CA, Washington, D.C., In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] 9] Experts predict that this therapy could receive full FDA approval as soon as 2023. [10] 5, 2019), [link]. [9]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

NOVEMBER 1, 2021

The Transaction is scheduled to close on or about November 15, 2021 , and subject to customary closing conditions and covenants. Closing of the Transaction is subject to customary closing conditions and the approval of the CSE. Key Transaction Highlights and Rationale. Diversified Product Portfolio and distribution. products.

Research and Development 52

Research and Development Edibles Vaping Seed-To-Sale 52

SpeedWeed

FEBRUARY 22, 2021

The new law states: “The member or board panel certifying parole release shall not impose on any parolee any condition that would prohibit or restrict … the presence of any cannabinoid metabolites in any bodily fluids of the person.”. The new law caps the number of state-licensed cannabis growers at 37 through early 2023.

Law 52

Law Legalization Marijuana Packaging 52